Older adults experiencing irreversible blindness may now be able to see thanks to a system relying on a wireless retinal implant and high-tech glasses ...

The manuscript concerns a fundamental and controversial question in Trypanosoma brucei biology and the parasite life cycle, providing further evidence that slender bloodstream forms can indeed infect ...

The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...

About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, "Proteomics Tools Report: Research and Clinical markets (2025-2030).

In participants with geographic atrophy due to age-related macular degeneration, a photovoltaic retina implant microarray (PRIMA) system leads to significant improvement in visual acuity.

Geographic atrophy, an advanced form of dry age-related macular degeneration, leaves almost five million people around the ...

A photovoltaic retinal implant shows promise as a way to improve vision in patients with advanced age-related macular ...

Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...

For more information on Bionano’s OGM solutions, visit www.bionano.com.

Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue growth and a raised full-year outlook. Investors are watching how recent ...

China Medical University leads a multi-institution team reporting that MTAP deficiency suppresses cytosolic nucleic acid ...